Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 10/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/20/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/20/20 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/02/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/01/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/01/20 | 5 | Annual statement of changes in beneficial ownership of securities |
|
2 |
